http://www.reportbuyer.com/rss.htmlIn this section you will find information products, including market research reports, on the following sector: Drug Discoveryen-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/optimizing_lifecycle_management_maximizing_commercial_lifespan_label_expansion_combination_products.htmlThe need to derive the maximum commercial mileage from all components of a drug company's portfolio is clearly evident in an era of falling returns on investment and higher capital costs. This report investigates three goals in optimizing product potential- expanding the drug's patent protected lifespan, accessing broader patient populations and launching line-extensions via fixed dose combinations. The key success factors in each of these pursuits have been clearly identified, emerging trends have been presented and the underlying concepts have been explained to provide a clear understanding of current industry dynamics. 300add16e34d0a89da62c7d36f350c46Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/cell_based_assays_drug_discovery.htmlThe area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-content screening (HCS) and analysis and is composed of those applications that require sufficient levels of sample throughput, whereby complex cellular events and phenotypes can be studied. Elements of drug performance like toxicity and specificity can be established simultaneously using mixed cell types-primary cells, cell lines, cell subpopulations. 6916ea6c621f12d25070cafbe0c2d3d1Sat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/software_tools_life_science_drug_discovery.htmlExecutive Summary This report examines the growing worldwide IT software and services market for the life science and drug discovery R&D community. The broad and high-level study takes a business focus and analyzes this interesting vertical market that supports key biomedical advancements. The emergence of big-budget, life science and drug discovery R&D initiatives sponsored by world governments and other players, combined with the rapid deployments of many types of new analytical instruments has created an incredible set of drug discovery opportunities and challenges for academic labs, R&D institutes and drug making companies alike. d88cfe59ebdd5b908fef0317c43b1474Wed, 17 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/indian_pharmaceutical_sector_industry_profile.htmlThis industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals. d0e225e8234e37392a0bf6acc9bc2373Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/canadian_pharmaceutical_sector_industry_profile.htmlThis industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals. d0965968c8c2a2a0a9b624493f3e0eb7Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/uk_pharmaceutical_sector_industry_profile.htmlThis industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals. b7f6ab094e8beb88f77b562380cf8431Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/us_pharmaceutical_sector_industry_profile.htmlThis industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the industry and analyzes the key trends and issues. The profile provides inputs in strategic business planning of industry professionals. d73655feadd73631dbf2eefbbe638fd6Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/pharmacogenomics_clinical_use_drug_development.htmlPharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. 67043e8e0b341eab70d34147c82ef971Sat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/key_trends_drug_diagnostic_co_development_identifying_collaborative_opportunities_navigating_regulatory_challenges.htmlThe development of genomics-based molecular diagnostics that are linked to therapeutic products is critical to targeted drug developments of the future. The potential for molecular diagnostics to be used as companion products for personalized treatments that are based on patient characteristics will contribute to a growing trend for new partnerships between drug companies and diagnostic firms. 'Key Trends in Drug-Diagnostic Co-Development' is a report published by Business Insights that explores the potential for applying genomic-based diagnostics to new drug developments, and the resultant implications for the pharma/biotech and diagnostic industries. 76e1f1db769b90528b9e06079073b7bdSat, 06 Jun 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/report_lipid_lowering_drugs_market.htmlChina's morbidity rate of hyperlipemia reaches above 7%, with 90 million patients, thus the lipid-lowering drugs market is a market of huge demand. This report analyzes the classification of hyperlipemia, drug market, and manufacturing enterprises, and mainly researches on the three types of lipid-lowering drugs (statin, nicotinic acid and its derivation, fibrate ) in current market. . 8dc3e91507ad61202f78b677ddda4ce3Tue, 05 May 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/new_drug_futures_2009.htmlThe search - and need - for new products has never been greater and what's in the development pipeline has never generated more interest. Major Therapy Areas Analysed Anti-infectives Cardiovascular CNS Gastrointestinal Metabolic Musculoskeletal Oncology Respiratory This 450-page report evaluates, compares and contrasts the prospects for the development compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond. That is why this analysis is so important! The Report Provides: Detailed background and market context for each therapy area covered: - Addressable patient population - Current treatments - Sales drivers - Sales breakers - Future treatments - Market dynamics - winners and losers - Key drug launches by 2013 Unique sales forecasts by major product to 2013 over 70 key products assessed Unique evaluation scores for key areas such as novelty of mechanism, clinical data and competition Critical and detailed appraisal of each product's research and development The Global Pharma Market in Context Too few novel products and an aggressive generic sector are taking their toll . 7683c334d0445d129a56c3e7dde17780Sat, 04 Apr 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/medicinal_chemistry_drug_discovery.htmlA thorough analysis of recent trends in medicinal chemistry and evaluation of their significance for advancing productivity in drug discovery is presented. This report includes: A critical evaluation of chemical and computational technological modalities, their current and potential value, and their commercial manifestations. A consideration of market dynamics with an emphasis on outsourcing and user views on the implications of current practices in drug discovery organizations. 85cba92e92373c39567ea37cd3dc3407Tue, 03 Mar 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/global_intravenous_iv_iron_drugs_market.htmlIron deficiency anemia or IDA is among one of the top ten most important public health issues, according to the World Health Organization. With approximately one-third of the current global population facing the problem of iron deficiency, more and more people are likely to suffer from a lack of iron in their diet in the near future due to changes in eating habits and rising life expectancy. Currently, iron supplements used in the context of IDA account for the majority share of the iron-based medicines but this is likely to change with the growing utility of intravenous iron (IV) drugs. de9c6f3270115ff6d3cd3e91c4718810Mon, 02 Feb 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/transforming_drug_discovery_genomics_proteomics.htmlIn medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. In the past most drugs have been discovered either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new approach has been to understand how disease and infection are controlled at the molecular and physiological level and to target specific entities based on this knowledge. 64b80231c8e6d853fc01cf455e324e32Thu, 01 Jan 2009 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/overview_european_drug_discovery_market.htmlThis research service gives a detailed analysis of the european drug discovery market from 2004-2014. . 4c4d422070b0ebc55b86b4a8b6eea098Fri, 12 Dec 2008 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/currently_druggable_colorectal_cancer.htmlNot surprisingly, an increasing number of companies have turned their attention to the cancer targeted therapy market, undoubtedly trying to emulate the blockbuster status that several brands have already achieved. This report aims to analyze the current and future potential of colorectal cancer pipeline by examining key fundamentals across the entire pipeline of drug candidates. BioSeeker has identified three fundamental dimensions to outline the competitive landscape within the pharmaceutical industry; compound type, therapy area and target type. e3c1040a44dad6c04af5053f5c8ce9f4Fri, 12 Dec 2008 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/breast_cancer_drug_discoveries_future_holds_2008.htmlThis report provides a comprehensive examination of all major breast cancer treatments, critical competitive evaluation of current and up and coming products and sales forecasts to 2014. . fe912cef845dede4f973c817ac738b1eFri, 12 Dec 2008 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/currently_druggable_melanoma.htmlThis report aims to analyze the current and future potential of melanoma pipeline by examining key fundamentals across the entire pipeline of drug candidates. BioSeeker has identified three fundamental dimensions to outline the competitive landscape within the pharmaceutical industry; compound type, therapy area and target type. This report is written for you to identify your competition and understand which targeting strategies are at work within melanoma drug development. f37f07fd656216b7d05b2720563fdc2bFri, 10 Oct 2008 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/drug_discovery_technologies_1.htmlThis report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. The specific technology types analyzed are Bioanalytical Instruments, High Throughput Screening (HTS), Biochip, Proteomics, Genomics, Bioinformatics, Pharmacogenomics, and Other Drug Discovery Technologies (Include Combinatorial Chemistry, Nanotechnology and RNAi). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe and Rest of World. 343681a63b013bb0fa06ce1a97ebf29aFri, 10 Oct 2008 12:00:00 GBPharma & Healthcare/Drug Discoveryhttp://www.reportbuyer.com/pharma_healthcare/drug_discovery/gpcrs_dawn_new_era.htmlCurrent advances in functional screening methodologies, medicinal chemistry, and structure-based drug design have generated large increases in the number and diversity of GPCR drug targets. Furthermore, basic research advances have opened the way for still further exploitation of this target class. This report: Explores current and likely consequences of recent advances concerning GPCR x-ray structures, allosteric interactions, multimerization, and functional selectivity; Extensively tabulates marketed drugs and compounds in development arranged by receptor type and subtype; Presents in-depth interviews with recognized experts in the field. 84e6a906a38b4a9172272cc112b9eeefFri, 10 Oct 2008 12:00:00 GBPharma & Healthcare/Drug Discovery